Anderson Orthopaedic Research Institute

What it reported doing in 2024

The funding received by the anderson orthopaedic research (aori) is used to conduct medical research and quality improvement activities related to hip and knee joint replacement. Aori conducts both prospective and retrospective studies with the ultimate goal of sharing the institute's findings with the broader medical community, including patients, through publications and presentations. Prospective studies, where volunteers consent to participate, are managed by aori's clinical research staff. These staff members help formulate study protocols, obtain institutional review board (irb) approval, consent participants, schedule follow-up visits, administer surveys, compile and analyze outcome data, prepare irb reports as necessary, summarize results for study sponsors, and prepare abstracts, presentations, and manuscripts for submission to scientific meetings and peer-review journals. Retrospective studies, which use pre-existing medical data, are conducted using information obtained as part of routine patient care and data derived from aori's electronic database that archives surgical procedures, clinical visits, patient-reported outcome measures, and adverse events. By analyzing this data, aori staff members are able to assess the outcome of different types of implants among unique groups of patients. The funding received by aori supports staff salaries and benefits, pays for fees charged by agencies that oversee aori's activities, and to purchase study supplies. Computers, laboratory testing equipment, and applications that enable the acquisition and compilation of study data are also paid for with the funds received by aori. During the past year, aori-affiliated researchers published 27 papers in orthopaedic journals. Aori researchers also presented 37 scientific talks, 18 posters at local and national orthopaedic meetings and 1 book chapter.

Financial Efficiency

• Mission deployment rate: 84.5%; rating input score 84
• Program expense ratio: 87.1%; rating input score 87
• Fundraising efficiency: $123.79 raised per $1 spent on fundraising; rating input score 88; 88th percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: 0 of 6 controls in place; rating input score 0
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Missing
  • Board or committee approval: Missing
• Foreign activity oversight: Limited
• Grant itemization coverage: Limited
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
• Governance controls: 7 of 9 controls in place; rating input score 78
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Missing
  • Independent financial-statement audit: Fail

Sustainability

• Operating margin: 41.5%; rating input score 90; 90th percentile among comparable filings
• Total-asset coverage ratio: 19.61; rating input score 96; 96th percentile among comparable filings
• Liabilities to assets ratio: 0.01; rating input score 66; 66th percentile among comparable filings
• Officer compensation ratio: 67.5%; rating input score 1; 1st percentile among comparable filings

Growth

• Program expense growth: -0% per year; rating input score 0; 18th percentile among comparable filings
• Revenue growth: 0.2% per year; rating input score 100; 15th percentile among comparable filings
• Asset growth: 6.8% per year; rating input score 100; 47th percentile among comparable filings